Ingredient news
Short, source-led updates on PS, phospholipids, supplement regulation, research, and functional ingredient markets.
News briefs
Each brief links to a full article with sectioned details and source links for verification.
FDA proposed making GRAS notifications mandatory for substances used in human and animal food, replacing the current voluntary program, with comments due December 9, 2026.
Read full story and sources
China's national standard GB/T 46804-2025, in effect since July 1, 2026, defines how phosphatidylserine content is measured in beverages, confectionery, convenience foods, and dairy products.
Read full story and sources
China's non-GMO liquid soya lecithin market strengthened in July 2026, with FOB Tianjin prices up 2.1% month on month to USD 1,200 per metric ton.
Read full story and sources
UNC researchers report that long-term choline restriction in mice remodeled liver lipid metabolism and drove insulin resistance through a CD36-ETNPPL regulatory axis.
Read full story and sources
A Fujita Health University mouse study found that soy-derived lysolecithin LPC70 lowered high-salt-diet blood pressure and improved social and memory deficits.
Read full story and sources
Two exploratory randomized trials of a standardized Ginkgo biloba extract combined with phosphatidylserine reported memory and reaction-time signals and mood improvements.
Read full story and sources
A prospective cohort study in the American Journal of Clinical Nutrition found choline source and solubility were differentially associated with dyslipidemia risk, with gut microbiota as a key modifier.
Read full story and sources
Danone Research and Innovation and the University of Lyon found that larger, milk phospholipid-coated lipid droplets were digested and absorbed differently than standard formula droplets in vitro.
Read full story and sources
Researchers developed soy lecithin nanoliposomes encapsulating Echinacea purpurea extract and showed the formulation inhibited bacteria and preserved quality in a chicken meat model.
Read full story and sources
Korean choline alfoscerate drugs failed the primary endpoint in a clinical reassessment for mild cognitive impairment, putting reimbursement and clawback outcomes in focus.
Read full story and sources
A randomized study in 32 enterally fed preterm infants found choline chloride, choline bitartrate, GPC, and egg phosphatidylcholine all raised plasma choline after 48 hours, with GPC acting fastest.
Read full story and sources
FSANZ approved milk fat globule membrane-enriched whey protein concentrate as a nutritive substance in infant formula products, and Arla says the decision gives its Lacprodan MFGM-10 exclusive Australian commercialization rights for at least 15 months.
Read full story and sources
A Journal of Dairy Science study found fluidized bed drying kept whey protein phospholipid concentrate closer to native protein structure and preserved more xanthine oxidase activity than spray drying.
Read full story and sources
A 4D lipidomics study found the largest phospholipid and ganglioside losses during initial milk centrifugation and additional composition shifts during churning, coagulation, and evaporation.
Read full story and sources
A food science study reported that the highest-phosphatidylcholine sunflower fraction produced the smallest oil droplets and strongest interfacial stability in model ice cream.
Read full story and sources
Researchers built high-internal-phase emulsions with sunflower lecithin, whey protein isolate, and sodium caseinate that stayed stable under heat, salt, and pH stress while improving beta-carotene bioaccessibility.
Read full story and sources
Kirin and Blackmores said new citicoline-based cognitive support products will begin rolling out in Australia and New Zealand from late July 2026.
Read full story and sources
A new adult meta-analysis reported modest reductions in total cholesterol, LDL cholesterol, apolipoprotein B, and the total-cholesterol-to-HDL ratio after short-term intake of bovine-derived MFGM or milk polar lipids.
Read full story and sources
A Food & Nutrition Research study found larger sleep-quality and mood improvements after three weeks of higher-dose Melissa phospholipids in adults with emotional distress.
Read full story and sources
A two-center observational cohort associated an oral citicoline combination with improvements in executive, memory, and mood measures in prodromal dementia and early Alzheimer-type decline.
Read full story and sources
A pediatric short bowel syndrome analysis found low plasma choline, betaine, and phosphatidylcholine levels, linking lower choline status with liver-steatosis risk.
Read full story and sources
A 12-week placebo-controlled study in Japan reported higher upper-arm skin hydration after daily dairy-derived sphingomyelin in healthy women.
Read full story and sources
A crossover study using matched high-fat dairy spreads found no acute postprandial triglyceride advantage from intact or disrupted milk fat globule membrane versus a comparator without MFGM.
Read full story and sources
Kyowa Hakko USA said Mintel and Black Swan Data identified Cognizin citicoline as a functional ingredient to watch, citing growing use across beverages, energy formats, and supplements.
Read full story and sources
Lekithos introduced a sunflower lecithin granule format aimed at dry-format use, adding another non-soy phospholipid option to the supplement and functional-food market.
Read full story and sources
O Positiv launched its first prenatal supplement, combining choline, omegas, iron, probiotics, ginger, and vitamin B6 in a single daily formula.
Read full story and sources
A randomized clinical study reported stronger load-related leg blood-flow responses and lower aortic stiffness after four weeks of oral phosphatidylserine in adults with type 2 diabetes.
Read full story and sources
A controlled infant-formula trial found no measurable body-composition advantage from large milk phospholipid-coated lipid droplets enriched in dairy lipids during the first two years of life.
Read full story and sources
A recent review says DHA supplied in phospholipid-rich formats can deliver higher intestinal bioavailability than standard triglyceride fish-oil supplements, while also raising cost and formulation tradeoffs.
Read full story and sources
A 2026 review argues that choline deficiency may remain a meaningful neural-tube-defect risk even in folic-acid-fortified markets, keeping phospholipid-linked prenatal nutrition on buyers' radar.
Read full story and sources
A placebo-controlled human trial testing five dietary emulsifiers, including soy lecithin, reported microbiome-related shifts and lower short-chain fatty acids but little change in inflammation endpoints.
Read full story and sources
A new narrative review calls choline an underused neurocognitive nutrient, linking prenatal intake gaps and limited human trial depth to a need for stronger formulation and clinical planning.
Read full story and sources
EFSA's latest novel-food opinion says L-alpha-GPC made from soya phospholipids is safe for food-supplement use at the proposed maximum intake, adding a fresh regulatory reference point for choline suppliers.
Read full story and sources
SmartyPants says its new Prenatal Plus Multivitamin Capsules deliver 480 mg of choline per daily serving, giving buyers another current read on how prenatal brands are increasing choline inclusion.
Read full story and sources
BEVIMI's new Uno Protect launch packages phospholipid-form omega-3s from Norwegian herring roe into a shelf-stable liquid shot, signaling continued premium interest in complex brain-lipid systems.
Read full story and sources
Sports Research says its Costco footprint now covers 10 wellness SKUs, including a krill-oil line built around phospholipid-bound omega-3s, choline, and sourcing transparency.
Read full story and sources
FDA's 2026 Human Foods Program agenda says final guidance on NDI safety and identity information is due this year, giving ingredient suppliers another reason to tighten master-file style documentation.
Read full story and sources
FDA's foods regulations agenda now lists a July 2026 proposed rule on when an ingredient is not excluded from the dietary supplement definition, giving ingredient developers another signal that category-boundary questions are moving from discussion toward formal rulemaking.
Read full story and sources
A randomized trial in children with ADHD or subthreshold symptoms found the highest-dose PS plus DHA formula outperformed placebo and lower-dose comparators on multiple attention and inhibition measures.
Read full story and sources
A 10-day trial in professional football players associated a taurine-caffeine-PS stack with better locomotor output, reaction time, and selected technical indicators, though the paper notes PS-specific attribution remains unresolved.
Read full story and sources
A pilot imaging study found oral choline changed working-memory-related brain activation and connectivity in postmenopausal women, even though measured task performance did not differ from placebo.
Read full story and sources
A temporal cohort study associated infant formula with added bovine MFGM with improved myelination in motor-related brain regions and better gross and fine motor scores.
Read full story and sources
Bobbie says its updated organic whole-milk infant formula rolled out across Target with positioning around MFGM, DHA, and choline, highlighting how complex lipid systems continue to shape premium formula design.
Read full story and sources
Standard Process says its Spirited Paw Healthy Mind launch combines phosphatidylserine with B vitamins, vitamin E, and MCT oil, extending PS use into aging-dog cognitive supplements.
Read full story and sources
A new review argues that choline's immune effects depend partly on form, with phosphatidylcholine and sphingomyelin highlighted as meaningful contributors to immune development and inflammation-related responses.
Read full story and sources
A Food Chemistry study reports that egg lecithin improved ultrasound-assisted egg-yolk-granule emulsions up to a threshold, after which excess lecithin displaced proteins and weakened interfacial stability.
Read full story and sources
FDA has scheduled a public meeting on dietary supplement innovation and the scope of dietary ingredients, keeping U.S. compliance strategy and document readiness in focus for ingredient suppliers and brand teams.
Read full story and sources
NIQ says South Korea's online cognitive-enhancement segment for Gen X posted sharp growth, with phosphatidylserine among the fastest-rising ingredients in the category.
Read full story and sources
Golden Key Ingredients has introduced PSgold, a powdered sunflower-derived phosphatidylserine positioned for capsule, tablet, and powdered-mix formulations.
Read full story and sources
O Positiv says its new MENO Brain product uses phosphatidylserine in a menopause-focused brain-fog concept, adding another mass-retail demand signal for cognitive-positioned ingredients.
Read full story and sources
Life Time's new LTH Dream formula includes phosphatidylserine alongside magnesium, pharmaGABA, and other sleep-support ingredients in a melatonin-free format.
Read full story and sources
A 2025 randomized trial of sunflower phosphatidylserine in healthy children found no significant overall differences on primary or secondary outcomes, while suggesting lower-performing subgroups may warrant further study.
Read full story and sources
A randomized placebo-controlled trial in Chinese older adults with mild cognitive impairment reported that a phosphatidylserine-containing supplement improved several cognitive measures, especially short-term memory.
Read full story and sources
A 2025 Frontiers in Nutrition study found that different supplemental choline forms produced distinct one-carbon metabolite patterns, with genetic variation influencing the response.
Read full story and sources
A 2024 Nutrients study found that alpha-glycerylphosphorylcholine supplementation improved Stroop-test performance in healthy young men, reinforcing demand for fast-acting choline formats in cognitive products.
Read full story and sources
A 2025 Perspective on future directions in choline says key questions remain around brain, liver, and cardiometabolic effects, highlighting ongoing demand for stronger biomarkers and more precise nutrition work.
Read full story and sources
FDA's GRAS inventory now shows a no-questions response for a sunflower lecithin notice, adding a current U.S. reference point for buyers tracking source options and technical dossiers.
Read full story and sources
Bunge says it has closed its acquisition of IFF's soy protein concentrate, lecithin, and crush assets, a move that strengthens scale in protein and phospholipid-adjacent ingredient supply.
Read full story and sources
A CRN-backed U.S. Senate proposal would create a federal dietary supplement registry, keeping market attention on listing, traceability, and product-file readiness.
Read full story and sources
Medella Springs says its new AddiVance formula is positioned for daily focus and attention support, adding another current phosphatidylserine use case in family-oriented supplement marketing.
Read full story and sources
Midi Health's first supplement line includes a Daily Cortisol Support formula with phosphatidylserine, extending PS use into women 40+ hormone and stress-positioned products.
Read full story and sources
A randomized trial of milk fat globule membrane phospholipids in older adults found no significant overall cognitive effect, though the high-dose group showed better subjective alertness during testing.
Read full story and sources
A recent dry-eye study of sunflower lecithin supplementation reported no significant improvement versus placebo, offering a cautionary evidence point for phosphatidylcholine-rich positioning.
Read full story and sources
A pediatric nutrition review argues that choline supply should be assessed more carefully across formulas, fortifiers, and supplements, keeping attention on phosphatidylcholine-linked ingredient design in early-life products.
Read full story and sources
A 2025 meta-analysis supports further study of choline supplementation during or after alcohol-exposed pregnancies, keeping prenatal choline evidence in focus for specialized nutrition developers.
Read full story and sources
A 2025 lecithin study in Chinese older adults and SAMP8 mice connects memory and muscle endpoints, widening interest in lecithin beyond standard emulsifier or choline-supply discussions.
Read full story and sources
Wellex a lancé un supplément en poudre combinant phosphatidylsérine, citicoline et créatine, reflétant l'utilisation continue de PS dans des produits nutritionnels multi-ingrédients.
Read full story and sourcesApprovisionnement en produits
Partagez la source, le test cible, l'application, la quantité annuelle et les documents requis avec les ventes de Nutranexa.
